SCHEMBL6947376

SCHEMBL6947376

Cc1cc(-c2nsnc2OCCN(C)C)ccc1Nc1c(C(=O)O)cc(F)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPK1 P28482 1/20 0.35
SYK P43405 1/20 0.34
P2RX7 Q99572 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
MELK Q14680 2/20 0.32
GFER P55789 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TNIK Q9UKE5 1/20 0.32
DHODH Q02127 2/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
ROCK2 O75116 1/20 0.32
IDO1 P14902 1/20 0.32
PIK3R1 P27986 1/20 0.31
PIK3CA P42336 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946730 0.92 MEN1 (0.36) MEN1KMT2ATDP1MAPK1SYK
SCHEMBL6941232 0.81 MEN1 (0.41) MEN1KMT2ATDP1MAPK1GFER
SCHEMBL6946757 0.76 MEN1 (0.39) MEN1KMT2ATDP1TNIKPIK3R1
SCHEMBL6945160 0.73 MEN1 (0.41) MEN1KMT2ATDP1MAPK1P2RX7
SCHEMBL6943774 0.73 MEN1 (0.56) MEN1KMT2ATDP1
SCHEMBL6945840 0.72 MEN1 (0.42) MEN1KMT2ATDP1MAPK1GFER
SCHEMBL6944936 0.68 MEN1 (0.67) MEN1KMT2ATDP1
SCHEMBL4853895 0.68 MEN1 (0.62) MEN1KMT2ATDP1MAPK1IDO1
SCHEMBL6950406 0.66 KMT2A (0.48) MEN1KMT2ATDP1MAPK1P2RX7
SCHEMBL6948716 0.65 AURKA (0.51) MEN1KMT2ATDP1MAPK1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP claimed
JP-2003504401-A 2003-02-04 JP claimed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP claimed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP claimed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO claimed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO claimed
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP disclosed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP disclosed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP disclosed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed